1.  For lymphoscintigraphy in patients with melanoma, the radiopharmaceutical is injected...?:

        Intramuscularly

        Intravenously

        Intradermally

        Subcutaneously

2.  The ideal radiopharmaceutical for lymphoscintigraphy is...?:

        Tc-SC incubated for 1 hr at 20ºC, then filtered

        Tc-SC incubated for 1 hr at 20ºC, not filtered

        Tc-SC heated to 100ºC, not filtered

        Tc-SC heated to 100ºC, then filtered

3.  Which one of the following is NOT an indication for performing a Lymphoscintigraphy study...?:

        Identification of primary breast tumors

        Localizing the sentinel node draining a breast tumor

        Localizing the drainage pattern of an excised melanoma

4.    The correct activity to use for lymphoscintigraphy of melanoma is...?:

        Single 1-mCi injection 3 cm below melanoma site

        Single 1-mCi injection 3 cm above melanoma site

        6 separate injections, 1 mCi each, around site of melanoma

5.     The ideal particle size to use for high quality lymphoscintigraphy studies is ?:

        ~100 mm

        ~10 mm

        ~1 mm

6.   In a comparison of deep vs surface injections for breast lymphoscintigraphy,?:

        Deep injections are more painful and more prone to failure

        Deep injections are less painful and more prone to failure

        Deep injections are more painful but less prone to failure

        Deep injections are less painful and less prone to failure

7.   Migration of the colloid is typically FIRST seen...?:

        As early as 15 min post injection

        As early as 60 min post injection

        As early as 2 hr post injection

8.    Lymphoscintigraphy with Tc-SC may be performed using ?:

        A PET Scanner

        A properly calibrated thyroid uptake probe

        A single head gamma camera

9.    Particle size distribution is most optimal for Tc-SC...?: 

        Prepared in a boiling water bath

          Prepared by room temperature incubation

          Prepared in a microwave oven

10.   For visualization of the internal mammary node chain, the radiopharmaceutical is injected?:

        Intramuscularly

        Intravenously

        Intradermally